Abstract
From the literature on the hepatitis C virus, the existence of a gap between a sustained virologic response (SVR) attainable in randomized clinical trials (RCTs) versus routine practice is not clear. Further, in terms of the pretreatment prediction of SVR, to date, studies have focused only on reporting the magnitude of association (MOA) between each predictor and an SVR. They fail to acknowledge that a predictor with a large MOA is of little value to clinicians if it has low variability in the treatment population.
Original language | English |
---|---|
Pages (from-to) | 646–655 |
Number of pages | 10 |
Journal | European Journal of Gastroenterology and Hepatology |
Volume | 24 |
Issue number | 6 |
DOIs | |
Publication status | Published - 2012 |
Keywords
- hepatitis C